Apollo Hospitals to announce Q4 results today: Here's what to expect
Apollo Hospitals anticipates a steady Q4, fueled by margin expansion and robust pharmacy growth. Analysts highlight improved digital traction from Apollo 24/7, potentially offsetting challenges from festive season softness and geopolitical issues ...

Here’s what to expect from Apollo Hospitals Q4
Consolidated EBITDA is expected to come in between Rs 770–788 crore, with margins improving 95 basis points YoY to around 13.9%. “Better mix, stable costs, and rising digital traction are aiding profitability,” Nuvama stated.
Analysts expect hospital revenues to grow 13% year-on-year, largely supported by patient volumes. “While the Bangladesh issue and festive impact may limit growth, core operating metrics remain stable,” the brokerage noted, adding that occupancy is likely to stay flat at 68%, while ARPOB could rise 4% YoY.
Motilal Oswal is slightly more cautious. “Sales/EBITDA is expected to grow 8.7%/20% YoY to Rs 5,360 crore/Rs 770 crore, led by improved case mix and better performance from the HealthCo division,” the firm said in its pre-result note.
Apollo Health & Lifestyle Ltd (AHLL), which houses the diagnostics and clinic business, is projected to grow 7.4% YoY in revenue. “Healthy execution across diagnostics, primary and secondary clinics continues to support segment growth,” according to Motilal.
Also read: Blue Water Logistics IPO allotment: Here's how you can check status
Pharmacy revenues are also expected to post mid-teen growth, keeping the segment aligned with company targets.
Key updates will be awaited on new hospital projects in Gurugram, Hyderabad, Kolkata, Pune, and Mysore, along with developments in Apollo’s insurance product and concierge service under the 24/7 ecosystem.
Download ET Markets APP